Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-07-11 5:27 pm Sale |
2022-07-07 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
100 100.000% |
-57,345,694 (-100.00%) |
Filing History |
| 2022-05-23 8:55 pm Unchanged |
2022-05-23 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 74.930% |
0 (Unchanged) |
Filing History |
| 2022-03-15 09:00 am Unchanged |
2022-03-15 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 74.930% |
0 (Unchanged) |
Filing History |
| 2022-02-18 8:47 pm Unchanged |
2022-02-17 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 75.150% |
0 (Unchanged) |
Filing History |
| 2022-02-14 11:43 am Sale |
2021-12-31 | 13G | Entasis Therapeutics Holdings Inc. ETTX |
Eventide Asset Management, LLC | 590,602 1.200% |
-288,939 (-32.85%) |
Filing History |
| 2022-02-01 6:34 pm Unchanged |
2022-02-01 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 75.150% |
0 (Unchanged) |
Filing History |
| 2022-01-18 5:27 pm Purchase |
2022-01-12 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
TPG GP A, LLC | 1,020,748 2.100% |
1,020,748 (New Position) |
Filing History |
| 2021-06-11 5:37 pm Purchase |
2021-06-11 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
57,345,794 75.500% |
29,345,794 (+104.81%) |
Filing History |
| 2021-05-03 5:19 pm Purchase |
2021-05-03 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Innoviva Inc. INVA |
44,807,844 70.600% |
7,462,050 (+19.98%) |
Filing History |
| 2021-03-04 06:17 am Sale |
2020-08-06 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Sofinnova Venture Partners IX L.P. | 0 0.000% |
-1,180,178 (Position Closed) |
Filing History |
| 2021-02-16 3:07 pm Sale |
2020-12-31 | 13G | Entasis Therapeutics Holdings Inc. ETTX |
Armistice Capital, LLC | 1,863,198 4.990% |
-1,647,783 (-46.93%) |
Filing History |
| 2020-09-08 4:29 pm Purchase |
2020-08-27 | 13G | Entasis Therapeutics Holdings Inc. ETTX |
Armistice Capital, LLC | 3,510,981 9.900% |
3,510,981 (New Position) |
Filing History |
| 2020-09-01 5:28 pm Purchase |
2020-09-01 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Innoviva Inc. INVA |
37,345,794 69.000% |
34,700,774 (+1311.93%) |
Filing History |
| 2020-08-31 3:10 pm Unchanged |
2020-08-27 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
28,000,000 67.800% |
0 (Unchanged) |
Filing History |
| 2020-08-11 4:30 pm Sale |
2020-08-06 | 13G | Entasis Therapeutics Holdings Inc. ETTX |
Novo Holdings A/S | 1,173,896 4.300% |
-1,007,947 (-46.20%) |
Filing History |
| 2020-07-09 4:48 pm Sale |
2020-07-02 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Clarus Lifesciences III L.P. | 1,339,836 4.900% |
-283,569 (-17.47%) |
Filing History |
| 2020-06-18 12:30 pm Sale |
2020-06-11 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Frazier Life Sciences VIII L.P. | 799,953 2.900% |
-250,000 (-23.81%) |
Filing History |
| 2020-06-16 1:54 pm Unchanged |
2020-06-11 | 13G | Entasis Therapeutics Holdings Inc. ETTX |
Novo Holdings A/S | 2,181,843 7.990% |
0 (Unchanged) |
Filing History |
| 2020-06-12 5:30 pm Purchase |
2020-06-11 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
28,000,000 67.800% |
28,000,000 (New Position) |
Filing History |
| 2020-05-01 5:01 pm Unchanged |
2019-04-22 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Clarus Lifesciences III L.P. | 1,623,405 11.100% |
0 (Unchanged) |
Filing History |